MAGNESIUM SULFATE Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Magnesium Sulfate, and when can generic versions of Magnesium Sulfate launch?
Magnesium Sulfate is a drug marketed by B Braun Medical Inc, Exela Pharma, Fresenius Kabi Usa, Hospira, Baxter Hlthcare Corp, Hq Spclt Pharma, Mylan Labs Ltd, Amneal, Gland Pharma Ltd, and Milla Pharms. and is included in nineteen NDAs.
The generic ingredient in MAGNESIUM SULFATE is magnesium sulfate. There are one hundred and forty-six drug master file entries for this compound. Seventeen suppliers are listed for this compound. Additional details are available on the magnesium sulfate profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Magnesium Sulfate
A generic version of MAGNESIUM SULFATE was approved as magnesium sulfate by FRESENIUS KABI USA on September 8th, 1986.
Summary for MAGNESIUM SULFATE
| US Patents: | 0 |
| Applicants: | 10 |
| NDAs: | 19 |
| Finished Product Suppliers / Packagers: | 8 |
| Raw Ingredient (Bulk) Api Vendors: | 137 |
| Clinical Trials: | 314 |
| Patent Applications: | 1,386 |
| Formulation / Manufacturing: | see details |
| What excipients (inactive ingredients) are in MAGNESIUM SULFATE? | MAGNESIUM SULFATE excipients list |
| DailyMed Link: | MAGNESIUM SULFATE at DailyMed |
Recent Clinical Trials for MAGNESIUM SULFATE
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Cukurova University | Phase 4 |
| Southeastern Ontario Academic Medical Organization (SEAMO) | Phase 4 |
| National Institutes of Health (NIH) | Phase 2 |
Pharmacology for MAGNESIUM SULFATE
Medical Subject Heading (MeSH) Categories for MAGNESIUM SULFATE
Anatomical Therapeutic Chemical (ATC) Classes for MAGNESIUM SULFATE
US Patents and Regulatory Information for MAGNESIUM SULFATE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Milla Pharms | MAGNESIUM SULFATE IN PLASTIC CONTAINER | magnesium sulfate | INJECTABLE;INJECTION | 209642-002 | Nov 8, 2021 | AP | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
| Hospira | MAGNESIUM SULFATE IN PLASTIC CONTAINER | magnesium sulfate | INJECTABLE;INJECTION | 020309-002 | Jun 24, 1994 | AP | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
| Gland Pharma Ltd | MAGNESIUM SULFATE IN PLASTIC CONTAINER | magnesium sulfate | INJECTABLE;INJECTION | 213917-001 | Jul 10, 2020 | AP | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
| Hospira | MAGNESIUM SULFATE IN PLASTIC CONTAINER | magnesium sulfate | INJECTABLE;INJECTION | 020309-004 | Jan 18, 1995 | AP | RX | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
| Gland Pharma Ltd | MAGNESIUM SULFATE IN PLASTIC CONTAINER | magnesium sulfate | INJECTABLE;INJECTION | 213917-002 | Jul 10, 2020 | AP | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
